SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trading with heightened volatility as investors weigh President Trumps latest rhetoric on the Iran conflict, which signaled a push to intensify pressure despite mixed signals regarding potential de-escalation timelines. The community is deeply divided, with some traders betting on further supply disruptions and a short squeeze while others view the price action as an overextended reaction driven by speculative headlines.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently the focal point of intense market volatility, driven by a highly anticipated Q1 delivery report and community speculation surrounding the upcoming SpaceX IPO. Investors are deeply divided, with bulls pointing to long-term energy and AI growth potential, while bears are aggressively highlighting concerns over declining core vehicle demand and ongoing margin pressures.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The S&P 500 is facing significant downward pressure as investors react to escalating geopolitical tensions in the Middle East and a sharp spike in oil prices, fueling fears of inflation and economic instability. Community sentiment remains highly divided and volatile, with market participants debating whether the current selloff is a necessary market correction or a result of artificial manipulation following conflicting leadership signals regarding the conflict.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and the online community actively debate the economic and geopolitical implications of the former President's latest address regarding the Iran conflict. The discussion is heavily polarized, with critics pointing to market volatility and concerns over rhetoric, while supporters remain focused on political alignment and ongoing market strategies.

Invesco QQQ Trust Series 1 - Units of beneficial interest

The Invesco QQQ Trust is experiencing heightened volatility as investors react to a lack of clear resolution in the ongoing Iran conflict, leading to widespread skepticism toward recent market rallies. Community discourse is dominated by debates over geopolitical instability, the impact of fluctuating oil prices, and deep frustration with what many perceive as market manipulation driven by inconsistent political rhetoric.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing intense market volatility and increased volume as speculation mounts over a potential acquisition by tech giants like Amazon or SpaceX, with the community actively debating whether current buyout rumors are substantiated or merely a play for leverage. Traders are closely tracking the intersection of GSAT's critical satellite spectrum assets, the long-standing Apple partnership, and the broader space industry land-grab for direct-to-device connectivity.

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.

Lipocine Inc

Lipocine is currently trending as investors focus on the company's progress with LPCN 1154 for postpartum depression, following the primary endpoint miss in a recent trial. The community is actively debating the company's future development path and potential for strategic partnerships, as stakeholders analyze the stock's long-term viability amid ongoing cash management and pipeline evaluations.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is gaining significant momentum as the community rallies around its upcoming one-year anniversary and anticipation for 4/20 festivities. Investors are actively discussing the project's long-term potential as a culture-driven asset, highlighting its mission to decentralize cannabis advocacy and its persistent organic growth.

Blue Owl Capital, Inc. operates as an alternative asset management firm. It provides investors access to asset management capital solutions through its Direct Lending and GP Capital Solutions products. The company offers a platform of capital solutions to both middle market companies and large alternative asset managers. The company was founded by Doug Irving Ostrover, Michael Rees and Craig W.Packer in 2009 and is headquartered in New York, NY.

Blue Owl Capital Inc - Ordinary Shares - Class A

Blue Owl Capital is trending due to heightened investor scrutiny regarding its private credit liquidity and redemption policies, alongside market-wide concerns about potential systemic risks in the private debt sector. Community discourse remains polarized, with some investors highlighting the firm's growth in AI data center financing as a long-term catalyst, while others express alarm over redemption caps and comparisons to past financial crises.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is experiencing a significant surge in investor attention following the acquisition of Apium Swarm Robotics and a new strategic partnership with Ukraine's Spetstechnoexport. The community is actively debating the company's long-term defense pipeline, the impact of recent military contract wins within NATO, and the volatility inherent in drone-sector plays as production scales to meet global demand.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amicus Therapeutics (NASDAQ:FOLD) Reaches New 1-Year High  - Still a Buy?

Amicus Therapeutics (NASDAQ:FOLD) Hits New 12-Month High - Here's What Happened...

210,800 Shares in Amicus Therapeutics, Inc. $FOLD Acquired by CIBRA Capital Ltd

CIBRA Capital Ltd bought a new stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange...

Why Is Adma Biologics (ADMA) Down 45.4% Since Last Earnings Report?

Adma Biologics (ADMA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Iovance Biotherapeutics (IOVA) Down 2.1% Since Last Earnings Report: Can It Rebound?

Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

JPMorgan Chase & Co. Sells 94,105 Shares of Amicus Therapeutics, Inc. $FOLD

JPMorgan Chase & Co. reduced its stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 4.3% during the third quarter, according to the company in its most recent 13F filing with...

BioMarin (BMRN) Down 13.6% Since Last Earnings Report: Can It Rebound?

BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Amicus Therapeutics (NASDAQ:FOLD) Hits New 52-Week High - What's Next?

Amicus Therapeutics (NASDAQ:FOLD) Hits New 1-Year High - What's Next...

Amicus Therapeutics (NASDAQ:FOLD) Hits New 52-Week High - Time to Buy?

Amicus Therapeutics (NASDAQ:FOLD) Sets New 1-Year High - Should You Buy...

872,411 Shares in Amicus Therapeutics, Inc. $FOLD Acquired by Ion Asset Management Ltd.

Ion Asset Management Ltd. purchased a new position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) during the third quarter, according to the company in its most recent disclosure...

Iron Triangle Partners LP Takes Position in Amicus Therapeutics, Inc. $FOLD

Iron Triangle Partners LP purchased a new stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the...

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Amicus Therapeutics Inc

Thematic ETFs

Prediction Markets

OpenClaw & Agentic-Directed Trading

Tokenization

Recognizing the tool or mechanism that redefined how we trade. From prediction markets to next-gen tech, this award honors the innovation that pushed the boundaries of access and efficiency in modern finance.

Current Price	$14.44
Prev Close	$14.46
Open	$14.46
Dividend Yield	0.00%
50-Day Moving Average	$14.35
Beta	0.80
Avg. Volume	3.78M
PE Ratio	-162.98

52-Week High	$14.46
52-Week Low	$5.51
Market Capitalization	$4.53B
EPS (Annual)	-$0.0879
Price to Book	16.37
Revenue Per Employee	$1.24M

FOLD
Amicus Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FOLD News

FOLDAmicus Therapeutics Inc